tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Compass Pathways’ Phase III Study on COMP360: A New Hope for Treatment-resistant Depression
PremiumCompany AnnouncementsCompass Pathways’ Phase III Study on COMP360: A New Hope for Treatment-resistant Depression
18d ago
COMPASS Pathways: Leading the Psychedelic Medicine Revolution with Promising Psilocybin Trials and Strong Industry Positioning
Premium
Ratings
COMPASS Pathways: Leading the Psychedelic Medicine Revolution with Promising Psilocybin Trials and Strong Industry Positioning
20d ago
Compass Pathways’ COMP360 Study: A New Hope for Treatment-resistant Depression?
Premium
Company Announcements
Compass Pathways’ COMP360 Study: A New Hope for Treatment-resistant Depression?
20d ago
Positive Buy Rating for COMPASS Pathways Driven by Strategic Progress and Financial Stability
PremiumRatingsPositive Buy Rating for COMPASS Pathways Driven by Strategic Progress and Financial Stability
24d ago
Compass Pathways’ Phase III Study on COMP360: A Potential Game-Changer in Depression Treatment
Premium
Company Announcements
Compass Pathways’ Phase III Study on COMP360: A Potential Game-Changer in Depression Treatment
24d ago
Psychedelic: Filament reports compassionate use approval for psilocybin
Premium
The Fly
Psychedelic: Filament reports compassionate use approval for psilocybin
24d ago
Compass Pathways Advances Psilocybin Study for Treatment-Resistant Depression
PremiumCompany AnnouncementsCompass Pathways Advances Psilocybin Study for Treatment-Resistant Depression
1M ago
Compass Pathways’ Psilocybin Study: A Potential Game-Changer for Depression Treatment?
Premium
Company Announcements
Compass Pathways’ Psilocybin Study: A Potential Game-Changer for Depression Treatment?
1M ago
Psychedelic: Clearmind expands trial for Alcohol Use Disorder
Premium
The Fly
Psychedelic: Clearmind expands trial for Alcohol Use Disorder
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100